Susan Dana Jones's most recent trade in Tourmaline Bio Inc was a trade of 58,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tourmaline Bio Inc | Susan Dana Jones | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 58,000 | 58,000 | - | - | Employee Stock Option (Right to Buy) |